Dr. Ferguson specializes in the surgical management of diseases of the chest. His most active areas of surgical management include lung cancer, benign and malignant esophageal diseases, mesothelioma, and thymoma. He has broad experience in using minimally invasive techniques, and performs 80% of his operations either using VATS, robotics, or laparoscopy. He is also adept at performing traditional open operations for more complex disease.
As founding Program Director of the University of Chicago Cardiothoracic Fellowship Program, Dr. Ferguson supervises the training of cardiothoracic fellows. He has served on the boards and committees of numerous national societies and institutions including the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and CTSNet.org.
Dr. Ferguson is the author of more than 100 chapters in medical textbooks. He has edited or written 8 books, and has completed 3 editions of Difficult Decisions in Thoracic Surgery. He is the editor for Difficult Decisions in Surgery, a series of books highlighting decision making in a variety of surgical subspecialties. He has also published more than 350 papers and abstracts in medical journals. Dr. Ferguson serves as a deputy editor for the Annals of Thoracic Surgery, is on the editorial board of 3 other journals, and is Editor of CTSNet.org. He serves as the Executive Director of the International Society for Diseases of the Esophagus.
Among his research interests are risk analysis, long-term outcomes after lung resection and esophageal resection, development of simulation methods for surgical training, advanced techniques in surgical education, and factors that influence medical decision making including gender and racial/ethnic bias. His educational background includes an undergraduate degree from Harvard College and an MD degree from The University of Chicago. His surgical training and fellowship in medical education took place at The University of Chicago.
University of Chicago
Chicago, IL
- Education
2011
University of Chicago
Chicago, IL
- Cardiothoracic Surgery
1984
University of Chicago
Chicago, IL
- General Surgery
1982
University of Chicago
Chicago, IL
MD
1977
Harvard College
Cambridge, MA
BA
1973
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.
Gutiontov SI, Turchan WT, Spurr LF, Rouhani SJ, Chervin CS, Steinhardt G, Lager AM, Wanjari P, Malik R, Connell PP, Chmura SJ, Juloori A, Hoffman PC, Ferguson MK, Donington JS, Patel JD, Vokes EE, Weichselbaum RR, Bestvina CM, Segal JP, Pitroda SP. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 Oct 08; 11(1):20059.
PMID: 34625620
Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer.
D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS, O'Neill JR, Hoelscher A, Piessen G, van Lanschot J, Wijnhoven B, Jobe B, Davies A, Schneider PM, Pera M, Nilsson M, Nafteux P, Kitagawa Y, Morse CR, Hofstetter W, Molena D, So JB, Immanuel A, Parsons SL, Larsen MH, Dolan JP, Wood SG, Maynard N, Smithers M, Puig S, Law S, Wong I, Kennedy A, KangNing W, Reynolds JV, Pramesh CS, Ferguson M, Darling G, Schröder W, Bludau M, Underwood T, van Hillegersberg R, Chang A, Cecconello I, Ribeiro U, de Manzoni G, Rosati R, Kuppusamy M, Thomas PA, Low DE. Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg. 2021 09 01; 156(9):836-845.
PMID: 34160587
Pulmonary Parenchymal Changes in COVID-19 Survivors.
Diaz A, Bujnowski D, McMullen P, Lysandrou M, Ananthanarayanan V, Husain AN, Freeman R, Vigneswaran WT, Ferguson MK, Donington JS, Madariaga MLL, Abdelsattar ZM. Pulmonary Parenchymal Changes in COVID-19 Survivors. Ann Thorac Surg. 2021 Jul 31.
PMID: 34343471
U.S. trends in elective and emergent major abdominal surgical procedures from 2002 to 2014 in older adults.
Rubin DS, Huisingh-Scheetz M, Ferguson MK, Nagele P, Peden CJ, Lauderdale DS. U.S. trends in elective and emergent major abdominal surgical procedures from 2002 to 2014 in older adults. J Am Geriatr Soc. 2021 08; 69(8):2220-2230.
PMID: 33969889
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial.
Madariaga MLL, Guthmiller JJ, Schrantz S, Jansen MO, Christensen C, Kumar M, Prochaska M, Wool G, Durkin-Celauro A, Oh WH, Trockman L, Vigneswaran J, Keskey R, Shaw DG, Dugan H, Zheng NY, Cobb M, Utset H, Wang J, Stovicek O, Bethel C, Matushek S, Giurcanu M, Beavis KG, di Sabato D, Meltzer D, Ferguson MK, Kress JP, Shanmugarajah K, Matthews JB, Fung JF, Wilson PC, Alverdy JC, Donington JS. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
PMID: 33034095
Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation.
Bryan DS, Ferguson MK, Antonoff MB, Backhus LM, Birdas TJ, Blackmon SH, Boffa DJ, Chang AC, Chmielewski GW, Cooke DT, Donington JS, Gaissert HA, Hagen JA, Hofstetter WL, Kent MS, Kim KW, Krantz SB, Lin J, Martin LW, Meyerson SL, Mitchell JD, Molena D, Odell DD, Onaitis MW, Puri V, Putnam JB, Seder CW, Shrager JB, Soukiasian HJ, Stiles BM, Tong BC, Veeramachaneni NK. Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. Ann Thorac Surg. 2021 08; 112(2):436-442.
PMID: 33127408
Thoracic ultrasound as a predictor of pleurodesis success at the time of indwelling pleural catheter removal.
Chaddha U, Agrawal A, Bhavani SV, Sivertsen K, Donington DJ, Ferguson MK, Murgu S. Thoracic ultrasound as a predictor of pleurodesis success at the time of indwelling pleural catheter removal. Respirology. 2021 03; 26(3):249-254.
PMID: 32929838
Multilevel Body Composition Analysis on Chest Computed Tomography Predicts Hospital Length of Stay and Complications After Lobectomy for Lung Cancer: A Multicenter Study.
Best TD, Mercaldo SF, Bryan DS, Marquardt JP, Wrobel MM, Bridge CP, Troschel FM, Javidan C, Chung JH, Muniappan A, Bhalla S, Meyers BF, Ferguson MK, Gaissert HA, Fintelmann FJ. Multilevel Body Composition Analysis on Chest Computed Tomography Predicts Hospital Length of Stay and Complications After Lobectomy for Lung Cancer: A Multicenter Study. Ann Surg. 2020 Jul 08.
PMID: 32773626
Outpatient Thoracoscopic Mediastinal Biopsy: A Safe and Cost-Effective Approach.
Brownlee AR, Mitzman B, Cyzman R, Ferguson MK. Outpatient Thoracoscopic Mediastinal Biopsy: A Safe and Cost-Effective Approach. Ann Thorac Surg. 2020 11; 110(5):1726-1729.
PMID: 32504602
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial.
Catenacci DVT, Chase L, Lomnicki S, Karrison T, de Wilton Marsh R, Rampurwala MM, Narula S, Alpert L, Setia N, Xiao SY, Hart J, Siddiqui UD, Peterson B, Moore K, Kipping-Johnson K, Markevicius U, Gordon B, Allen K, Racette C, Maron SB, Liao CY, Polite BN, Kindler HL, Turaga K, Prachand VN, Roggin KK, Ferguson MK, Posner MC. Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
PMID: 32058557